# "Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"

> **NCT03591003** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire Saint Pierre** · enrollment: 200 (actual)

## Conditions studied

- HIV Infections
- Yellow Fever Vaccine

## Interventions

- **DIAGNOSTIC_TEST:** Yellow fever neutralizing antibodies measure

## Key facts

- **NCT ID:** NCT03591003
- **Lead sponsor:** Centre Hospitalier Universitaire Saint Pierre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2023-01
- **Final completion:** 2023-03
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03591003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03591003, ""Persistence of Neutralizing Antibodies Against Yellow Fever (YF) in HIV-infected Patients"". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03591003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*